SCHEMBL5044764

SCHEMBL5044764

O=c1[nH]c2c(F)c(F)ccc2nc1CCN1CC[CH]CC1

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 7/20 0.32
PARP2 Q9UGN5 3/20 0.32
GABRP O00591 1/20 0.31
GABRD O14764 1/20 0.31
GABRA1 P14867 1/20 0.31
GABRB1 P18505 1/20 0.31
GABRG2 P18507 1/20 0.31
GABRB3 P28472 1/20 0.31
GABRA5 P31644 1/20 0.31
GABRA3 P34903 1/20 0.31
GABRA2 P47869 1/20 0.31
GABRB2 P47870 1/20 0.31
GABRA4 P48169 1/20 0.31
GABRE P78334 1/20 0.31
GABRA6 Q16445 1/20 0.31
GABRG1 Q8N1C3 1/20 0.31
GABRG3 Q99928 1/20 0.31
GABRQ Q9UN88 1/20 0.31
NPC1 O15118 1/20 0.30
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3847249 0.79 HRH4 (0.42) PARP1PARP2NPC1HTTRAB9A
SCHEMBL5047668 0.77 HSD17B10 (0.35) PARP1SMN1; SMN2KCNH2
SCHEMBL5047576 0.72 EGLN1 (0.37) PARP1PARP2KCNH2
SCHEMBL4733245 0.71 NPSR1 (0.46) NPC1RAB9ASMN1; SMN2
SCHEMBL5047854 0.69 MAPK10 (0.42) PARP1NPC1HTTRAB9ASMN1; SMN2
SCHEMBL604714 0.68 HRH4 (0.56) PARP1
SCHEMBL600883 0.66 HRH4 (0.41) KCNH2
SCHEMBL30212587 0.63 PARP1 (0.46) PARP1PARP2
SCHEMBL3846941 0.62 KCNH2 (0.47) PARP1PARP2SMN1; SMN2KCNH2
SCHEMBL25899507 0.61 MAPT (0.42) PARP1PARP2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1893599-A1 COMPOUNDS FOR THE TREATMENT OF MULTI-DRUG RESISTANT BACTERIAL INFECTIONS AstraZeneca AB (SE) 2008-03-05 EP disclosed
WO-2006134378-A1 COMPOUNDS FOR THE TREATMENT OF MULTI-DRUG RESISTANT BACTERIAL INFECTIONS ASTRAZENECA AB (SE) 2006-12-21 WO disclosed